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INTRODUCTION

S
ilicone oil was first used as an intraocular tamponade in humans by Cibis et al [1] in 1962 in retinal detachments with proliferative vitreoretinopathy (PVR). Silicone oils are hydrophobic compounds constituted of silicone and oxygen bonds. Silicone oils are chemically inert which is advantageous for intraocular use as they can remain in situ for an extended period of time.
Silicone oil tamponade is intended to be temporary as prolonged intraocular duration may lead to ocular complications, such as oil emulsification, band keratopathy, elevated intraocular pressure and cataract formation [2] . They are also potentially retinotoxic with reported cases of permanent central vision loss following removal of silicone oil (ROSO) [3] . In certain patients ROSO may not be appropriate due to patient preference, fitness for surgery or eyes with a high risk of redetachment or no visual potential. The main indications for silicone oil tamponade are retinal detachment (RD) complicated by PVR, giant retinal tears (GRT), traumatic RD and certain cases of proliferative diabetic retinopathy (PDR) with combined tractional rhegmatogenous retinal detachment (TRRD). PVR, the most common indication for oil tamponade, is a disease that complicates rhegmatogenous retinal detachment (RRD). The critical factor in developing PVR is the presence of a full thickness retinal break. PVR involves the migration of retinal pigment epithelial (RPE) and glial cells through a retinal break and proliferation on the retinal surface. They form a contractile fibrocellular membrane on the surface of the retina and beneath it leading to fibrosis, traction and subsequent RD [4] . PVR can occur in longstanding primary RD (primary PVR) but the majority of cases occur with redetachment after initial RD repair. Risk factors for PVR include uveitis, vitreous haemorrhage, giant or multiple retinal tears, aphakia, pre-or post-operative choroidal detachments, large detachment involving greater than two retinal quadrants [4] [5] . PVR complicates 5%-10% of RD surgery and is the most common cause of surgical failure in RRD [4] . Classification of PVR is currently based on the updated Retina Society Guidelines 1991 [6] . The primary objective of this study was to report anatomic and visual outcome following silicone oil removal at varying duration of tamponade in a cohort of patients with complex RD requiring silicone oil. Secondary objectives were to compare patients with oil removed and those with oil in situ in terms of associated factors.
SUBJECTS AND METHODS
All procedures performed in this study were in accordance with the guidelines set out by the Irish Council for Bioethics on audit studies section 2.2 and with the principles outlined in the 2008 Declaration of Helsinki. All retinal detachments that underwent silicone oil tamponade over a four years period were retrospectively examined. This case series included 143 eyes of 143 patients who underwent pars plana vitrectomy (PPV) with intraocular silicone oil injection from January 2012 to December 2015 at a Tertiary Ophthalmology Referral Centre. All surgeries were carried out by two vitreoretinal surgeons. Data was gathered on patient demographics, baseline vision, indications for and duration of oil tamponade, number of surgeries required, final anatomic and functional status. Best corrected visual acuity (BCVA) was measured by Snellen visual acuity at each clinic visit. Inclusion criteria were patients who underwent silicone oil tamponade for each of the following clinical scenarios: 1) retinal detachment with PVR; 2) GRT associated RD; 3) traumatic retinal detachment; 4) other, as specified. Exclusion criteria were patients with tractional retinal detachment (TRD) as a consequence of PDR. The primary outcome measures were anatomic success and visual outcome following silicone oil removal. Anatomic success was defined as complete retinal attachment following oil removal at 6mo or at patients most recent follow up visit. Significant improvement or deterioration in BCVA was based on ≥0.3 logMAR unit change in BCVA [7] . Ambulatory visual acuity (VA) was defined as 1.7 logMAR unit or better [8] . to logMAR units for analysis [9] . A BCVA of count fingers (CF), hand motions (HM), perception of light (PL), and no perception of light (NPL) were assigned 2.1, 2.4, 2.7 and 3.0 respectively, in keeping with those values used by the United Kingdom National Ophthalmology Database study of vitreoretinal surgery [10] . Figure 2B ). No correlation was found between duration of oil tamponade and final BCVA (r 2 =0.0036, P=0.5990; Figure 2C ).
Secondary Outcome Measures
Results of analysis between patients with oil removed and oil in situ are summarised in Table 3 . The mean baseline and final BCVA was significantly better in those with oil removed (P=0.0001 and <0.0001, respectively; Figure 3 ). Tamponade duration, the number of surgeries and presence of PVR in this series were not statistically significant. The final attachment rate is significantly higher (80%) of those with oil removed compared to those under tamponade (20%) (P=0.0044) as summarised in Table 4 . Those with oil in situ include patients who underwent ROSO and redetached. DISCUSSION Silicone oil tamponade is the method of choice for management of high risk/complex retinal detachment complicated by PVR, due to a giant retinal tear, post trauma ± intraocular foreign body (IOFB) and combined TRD/RRD in diabetic retinopathy. Despite surgical advances, redetachment following removal of oil is still common and the prospect of a deterioration in vision post oil removal is now well described. We sought to determine the risk of redetachment and long term VA based on duration of tamponade by assessing the practice, patient profile and outcomes at an Irish Tertiary Retinal Centre. This study presents the results of 143 patients diagnosed with complex retinal detachments treated with intraocular silicone oil tamponade. In terms of anatomic outcome the retinal redetachment rate following silicone oil removal of 9.4% in this series, corresponds favourably with redetachment rates reported in the literature of 6% to 34% [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . A large case series by Teke et al [24] reported 897 eye showed a redetachment rate of 12.2% in 2014, and an Irish series in 2007 reported final redetachment rate of 13.9% [25] . In this series mean number of surgeries was higher in the redetached group but number of surgeries was not associated with final attachment status (P=0.2015, Fisher's exact test). The optimal timing for silicone oil removal remains unclear on literature review.
Recommendations range from 3 to 6mo of sustained retinal attachment [26] [27] . In this series, the duration of oil tamponade had no significant effect on anatomic outcomes which corresponds with other reported studies [19] [20] 28] . Others reported a higher redetachment rate with shorter duration of tamponade, such as Lam et al [21] , in which tamponade of less than 2mo
was associated with higher risk of redetachment. This is a shorter duration compared to our series in which, 96.5% had tamponade of >2mo duration. In terms of visual outcomes, in this series an improvement or stability in BCVA at final up compared to baseline was seen in 80.8% of patients. This corresponds favourably with others reported were 38.9% [29] , 64.2% [28] and 84% [30] . A better baseline BCVA correlated positively to a better final BCVA using linear regression (r 2 =0.2201, P=0.0001).
Comparing the oil removed to oil in situ cohort both baseline and final BCVA was significantly better in the oil removed cohort. The refractive error induced by oil may be a factor in final BCVA and as we have shown above a better baseline BCVA correlates to better final vision. Also the redetachment rate was significantly lower in the oil out cohort. These results correlate with another Irish study comparing patients with oil removed versus oil in situ [30] . The main limitation of this study is its retrospective and noncomparative design and patient's records were not standardised. In this study, we report on 143 patients who underwent silicone oil tamponade for complex retinal detachments. Our outcomes are in keeping with those reported in the literature. Favourable visual outcomes were seen with oil removal. Duration of oil tamponade did not correlate with anatomic success or visual outcome. To conclude, based on these findings, the optimal timing of silicone oil removal should be managed on a case by case basis guided by individualised risks, patient preference and surgeon preference. 
